These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6606863)

  • 1. A reanalysis of the HLA-B7 cross-reactive group.
    Darke C
    Tissue Antigens; 1983 Nov; 22(5):326-34. PubMed ID: 6606863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A serological study of the HLA-B17 cross-reactive group.
    Darke C
    Tissue Antigens; 1984 Mar; 23(3):141-50. PubMed ID: 6203186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HLA-B12 and -B40 cross-reactive groups and their serological relationships.
    Darke C
    Tissue Antigens; 1983 Apr; 21(4):281-95. PubMed ID: 6190263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-Bw22: a family of molecules with identity to HLA-B7 in the alpha 1-helix.
    Hildebrand WH; Madrigal JA; Little AM; Parham P
    J Immunol; 1992 Feb; 148(4):1155-62. PubMed ID: 1737933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HLA-B7,B27,Bw42,Bw54,Bw55,Bw56, Bw67,Bw73 monoclonal antibodies: specificity, idiotypes, and application for a double determinant immunoassay.
    Sakaguchi K; Ono R; Tsujisaki M; Richiardi P; Carbonara A; Park MS; Tonai R; Terasaki PI; Ferrone S
    Hum Immunol; 1988 Mar; 21(3):193-207. PubMed ID: 3259570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA antigens in Reiter's syndrome in Israeli patients.
    Ben-Chetrit E; Brautbar C; Rubinow A
    J Rheumatol; 1985 Oct; 12(5):964-6. PubMed ID: 3878883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of responder cell activity in mixed leukocyte culture reactions. II. Influence of antibody binding and shedding properties within a B7-cross-reactivity group.
    de Rooij-Doyer E; Schoen MA; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Oct; 18(4):205-16. PubMed ID: 6178176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of HLA-Bw73 by serology and one-dimensional isoelectric focusing patterns.
    Eynon EE; Yang SY; Cronin CR; Alosco SM; Alper CA; Yunis EJ
    Hum Immunol; 1986 Aug; 16(4):356-63. PubMed ID: 2428782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive HLA antigens in B27-negative Reiter's syndrome and sacroiliitis.
    Arnett FC; Hochberg MC; Bias WB
    Johns Hopkins Med J; 1977 Oct; 141(4):193-7. PubMed ID: 909215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B POT: a new HLA-antigen within the B7-cross reactive group.
    Reekers P; van der Beucken M; Andrien M; Beelen J; Mueller-Eckhardt G; Schreuder GM
    Tissue Antigens; 1986 Sep; 28(3):182-9. PubMed ID: 2431514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inclusion of HLA-Bw42, Bw54 and Bw55 within the HLA-B14 cross-reactive group.
    Darke C
    Tissue Antigens; 1983 Mar; 21(3):246-53. PubMed ID: 6190262
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in conformation with loss of alloantigenic determinants of a histocompatibility antigen (HLA-B7) induced by monoclonal antibodies.
    Parham P
    J Immunol; 1984 Jun; 132(6):2975-83. PubMed ID: 6202768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-CREG and ankylosing spondylitis.
    Khan MA
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):129-33. PubMed ID: 6606463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cross-reacting HLA-B alleles as genetic markers of HLA-B27 negative ankylosing spondylitis].
    Haberhauer G; Bröll H
    Z Rheumatol; 1986; 45(5):260-2. PubMed ID: 3492838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public antigenic determinant on a family of HLA-B molecules.
    Schwartz BD; Luehrman LK; Rodey GE
    J Clin Invest; 1979 Oct; 64(4):938-47. PubMed ID: 90060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of responder cell activity in mixed leukocyte culture reactions. I. Evidence of cross-reactivity of B7-antibody with HLA-B8.
    de Rooij-Doyer E; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Sep; 18(3):154-65. PubMed ID: 7336421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undifferentiated spondyloarthropathies in Brazilians: importance of HLA-B27 and the B7-CREG alleles in characterization and disease progression.
    Sampaio-Barros PD; Conde RA; Donadi EA; Kraemer MH; Persoli L; Coimbra IB; Costallat LT; Samara AM; Bértolo MB
    J Rheumatol; 2003 Dec; 30(12):2632-7. PubMed ID: 14719206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of monoclonal antibodies to cell surface molecules. Quantitative analysis of the reactions and cross-reactions of an antibody (MB40.3) with four HLA-B molecules.
    Parham P
    J Biol Chem; 1984 Nov; 259(21):13077-83. PubMed ID: 6333424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [B27-negative spondylarthritis. Results of 3 familial surveys, with monozygotic twins in one].
    Chales G; Fauchet R; Gueguen M; Bled B; Frocrain L; Rolland C; Pawlotsky Y
    Rev Rhum Mal Osteoartic; 1987 Mar; 54(3):179-85. PubMed ID: 3495860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.